148 related articles for article (PubMed ID: 26992638)
21. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-488-3p sensitizes malignant melanoma cells to cisplatin by targeting PRKDC.
Li N; Ma Y; Ma L; Guan Y; Ma L; Yang D
Cell Biol Int; 2017 Jun; 41(6):622-629. PubMed ID: 28328082
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
24. Silencing of long non-coding RNA SBDSP1 suppresses tumor growth and invasion in colorectal cancer.
Shi D; Liang L; Zheng H; Cai G; Li X; Xu Y; Cai S
Biomed Pharmacother; 2017 Jan; 85():355-361. PubMed ID: 27890432
[TBL] [Abstract][Full Text] [Related]
25. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
27. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
28. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
29. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
30. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
32. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
33. Knock-Down of HOXB8 Prohibits Proliferation and Migration of Colorectal Cancer Cells via Wnt/β-Catenin Signaling Pathway.
Li X; Lin H; Jiang F; Lou Y; Ji L; Li S
Med Sci Monit; 2019 Jan; 25():711-720. PubMed ID: 30677006
[TBL] [Abstract][Full Text] [Related]
34. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
[No Abstract] [Full Text] [Related]
35. siRNA high-throughput kinase library screen identifies protein kinase, DNA-activated catalytic polypeptide to play a role in MyD88-induced IFNA2 activation and IL-8 secretion.
Charlaftis N; Fearon DT; Schoenemeyer A; Morley PJ
Biotechnol Appl Biochem; 2012; 59(1):6-14. PubMed ID: 22332739
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
[TBL] [Abstract][Full Text] [Related]
37. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
Qin AC; Li Y; Zhou LN; Xing CG; Lu XS
Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440
[TBL] [Abstract][Full Text] [Related]
38. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract][Full Text] [Related]
39. PRKDC is a prognostic marker for poor survival in gastric cancer patients and regulates DNA damage response.
Zhang Y; Wen GM; Wu CA; Jing ZL; Li DZ; Liu GL; Wei XX; Tang MS; Li YH; Zhong Y; Deng YJ; Yang WK
Pathol Res Pract; 2019 Aug; 215(8):152509. PubMed ID: 31255330
[TBL] [Abstract][Full Text] [Related]
40. HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion.
Feng Y; Xu X; Zhang Y; Ding J; Wang Y; Zhang X; Wu Z; Kang L; Liang Y; Zhou L; Song S; Zhao K; Ye Q
Sci Rep; 2015 Mar; 5():9429. PubMed ID: 25800793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
